National push to protect Canada's tiniest patients from dangerous hospital infections
NCT ID NCT07109791
Summary
This study aims to create better, nationwide guidelines for preventing and treating ventilator-associated pneumonia (VAP) in very small, premature babies. Researchers will collect data from 1,500 infants across Canadian hospitals to understand how often these infections happen, what causes them, and how they are currently treated. The goal is to develop a clear, standard approach to reduce infection rates, avoid unnecessary antibiotics, and improve outcomes for these vulnerable newborns.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTILATOR-ASSOCIATED PNEUMONIA (VAP), NEONATAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Royal Alexandra Hospital
RECRUITINGEdmonton, Alberta, T5H 3V9, Canada
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.